Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2023-06-07
DOI
10.1001/jama.2023.9106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OPTN/SRTR 2021 Annual Data Report: Kidney
- (2023) Krista L. Lentine et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
- (2022) Diana D. Wong et al. Microbiology Spectrum
- Risk factors for cytomegalovirus infection and disease after kidney transplantation: A meta-analysis
- (2022) Yan Tang et al. TRANSPLANT IMMUNOLOGY
- Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report
- (2021) Stefania Paolucci et al. BMC INFECTIOUS DISEASES
- 1380. Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-)
- (2021) Caroline G Roumpz et al. Open Forum Infectious Diseases
- Use of Letermovir as Salvage Therapy for Drug-resistant CMV Retinitis: A Case Series
- (2019) Nicholas Turner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
- (2019) Cameron M Douglas et al. JOURNAL OF INFECTIOUS DISEASES
- The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
- (2018) Camille N. Kotton et al. TRANSPLANTATION
- Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review
- (2018) M. Cintra-Cabrera et al. TRANSPLANTATION PROCEEDINGS
- Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection
- (2018) Lauren Cherrier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report
- (2017) I.A. Echenique et al. TRANSPLANTATION PROCEEDINGS
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
- (2016) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Unknown
- (2016) TRANSPLANT INTERNATIONAL
- Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment
- (2012) Elena Beam et al. Current Infectious Disease Reports
- The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
- (2011) T. Goldner et al. JOURNAL OF VIROLOGY
- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
- (2010) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started